home / stock / avro / avro news


AVRO News and Press, AVROBIO Inc. From 01/30/24

Stock Information

Company Name: AVROBIO Inc.
Stock Symbol: AVRO
Market: NASDAQ
Website: avrobio.com

Menu

AVRO AVRO Quote AVRO Short AVRO News AVRO Articles AVRO Message Board
Get AVRO Alerts

News, Short Squeeze, Breakout and More Instantly...

AVRO - AVROBIO and Tectonic Therapeutic Announce Merger

Combined company to be Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Tectonic’s novel GPCR-targeted therapeutic proteins $130.7 million in private financing commitments with new and existing leading life sciences investors in connection with merger ...

AVRO - Expected earnings - AVROBIO Inc.

AVROBIO Inc. (AVRO) is expected to report $-0.23 for Q3 2023

AVRO - Avrobio: Net-Net Biotech Pursuing Strategic Alternatives

2023-08-12 04:03:14 ET Summary After monetizing one of its pipeline candidates, Avrobio has cash well in excess of its market cap. The company announced its search for strategic alternatives recently. The process could close its valuation gap soon. There is potential for signi...

AVRO - Getting Started Trading Penny Stocks? Top Tips

2023-07-13 06:07:00 ET Top Tips for Getting Started With Buying Penny Stocks Understanding the fascinating world of penny stocks can present an attractive opportunity for investors looking to diversify their portfolio. At its essence, these are securities offered by small companies ...

AVRO - AVROBIO to Explore Strategic Alternatives

AVROBIO, Inc . (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that it has completed a review of its business, including the status of its programs, resources, and capabilities. AVROBIO has made the determi...

AVRO - Avrobio completes sale of gene therapy program to Novartis for $87.5M

2023-06-12 11:00:58 ET Avrobio ( NASDAQ: AVRO ) said it has completed the sale of its gene therapy program for the treatment of cystinosis to Novartis ( NYSE: NVS ) for $87.5M in cash, which should extend the biotech company's cash runway into Q4 2024. The sale was for A...

AVRO - AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million

All-cash transaction, full $87.5 million paid at closing Proceeds expected to extend cash runway into Q4 2024 AVROBIO, Inc . (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced the closing o...

AVRO - Avrobio, Cardiff Oncology top healthcare gainers; Vaxart, Carisma among losers

2023-06-07 10:01:47 ET Gainers: Avrobio ( AVRO ) +10% . Cardiff Oncology ( CRDF ) +8% . IceCure Medical ( ICCM ) +7% . Humacyte ( HUMA ) +6% . TScan Therapeutics ( TCRX ) +4% . Losers: Vaxart ( VXRT ) -27% . Carism...

AVRO - MVIS, BIOC and MANU are among pre market gainers

2023-06-07 08:35:50 ET Farmer Bros ( FARM ) +61% expands coffee business with deal for Farmer Brothers' facility Chijet Motor Company ( CJET ) +33% . VersaBank ( VBNK ) +25% Q2 earnings call release SaverOne 2014 ( SVRE ) +25% Additional 40 Instal...

AVRO - How to Handle Penny Stocks Volatility in 2023

2023-05-23 06:00:00 ET 3 Tips for Handling High Volatility When Trading Penny Stocks Penny stocks continue to offer incredible opportunities for investors in 2023. As high-growth, micro-cap equities, they have the potential to outperform traditional stocks, particularly given their inhe...

Previous 10 Next 10